Skip to main content

HomeResearchAngiotensin (1-7)

CategoryLongevity
SafetyLow Risk
StatusResearch Only

Angiotensin (1-7)

Ang-(1-7) · Ang 1-7 · MasR agonist · ACE2 product

CategoryLongevity
Half-life
Routesubcutaneous, intravenous
RiskLow Risk
ProvidersNone listed

About Angiotensin (1-7)

Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.

A heptapeptide formed from angiotensin II via ACE2 cleavage, or from angiotensin I via neprilysin. Acts as the endogenous counter-regulatory axis to angiotensin II — producing vasodilation, anti-fibrotic, and metabolic benefits via the Mas receptor.

Research Areas

cardiovascular protectionanti-fibroticvasodilationinsulin sensitivity

Regulatory & Evidence

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Low Risk

Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.

Reported contraindications & considerations

Cardiovascular ConditionKidney Or Liver ConditionPregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find Angiotensin (1-7)

Coverage expanding

No verified providers currently list Angiotensin (1-7). Get notified when one does, or explore providers carrying similar peptides in the Longevity category.

Frequently Asked Questions — Angiotensin (1-7)

A heptapeptide formed from angiotensin II via ACE2 cleavage, or from angiotensin I via neprilysin. Acts as the endogenous counter-regulatory axis to angiotensin II — producing vasodilation, anti-fibrotic, and metabolic benefits via the Mas receptor.

cardiovascular protection, anti-fibrotic, vasodilation, insulin sensitivity, kidney protection.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.